Income Statement
XBIOTECH INC.
XBIT
Performance Overview
Click any row in the table to add it to this chart
in millions USD
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY | Dec 31, 2019 2019 FY | Dec 31, 2018 2018 FY | Dec 31, 2017 2017 FY | Dec 31, 2016 2016 FY | Dec 31, 2015 2015 FY |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Revenue
|
- | - | - | - | - | - | - | - | - | - | - |
|
Cost of Revenue
|
- | - | 0.00 | 0.65 | 5.82 | 34.55 | - | - | - | - | - |
|
Gross Profit
|
- | - | 0.00 | 3.36 | 12.57 | 9.45 | - | - | - | - | - |
|
Operating Expenses
|
-55.69 | -42.47 | 37.51 | 37.85 | 37.66 | 27.73 | 31.23 | 20.99 | 34.06 | 52.76 | 37.51 |
|
Research & Development
|
47.39 | 37.76 | 32.85 | 31.54 | 28.27 | 9.53 | 24.09 | 15.73 | 26.42 | 42.49 | 31.31 |
|
Selling, General & Administrative
|
8.30 | 4.71 | 4.66 | 6.31 | 9.39 | 18.20 | 7.14 | 5.27 | 7.64 | 10.28 | 6.20 |
|
Other Operating Expenses
|
- | - | - | - | - | - | - | - | - | - | - |
|
Operating Income
|
-55.69 | -42.47 | -37.51 | -34.49 | -25.08 | -18.28 | -31.23 | -20.99 | -34.06 | -52.76 | -37.51 |
|
Non-Operating Income
|
10.38 | 3.91 | 13.20 | 0.90 | -0.38 | 5.45 | 749.69 | -0.14 | 0.91 | 0.00 | 0.03 |
|
Interest Income
|
- | - | - | - | - | - | - | - | - | - | - |
|
Interest Expense
|
- | - | - | - | - | - | - | - | - | - | - |
|
Other Non-Op Income / Expense
|
1.46 | 0.43 | 0.88 | -0.12 | -0.13 | -0.50 | - | - | - | - | - |
|
Income Before Tax
|
-45.31 | -38.56 | -24.31 | -33.59 | -25.46 | -12.83 | 718.45 | -21.14 | -33.15 | -52.76 | - |
|
Income Tax Expense
|
0.24 | -0.03 | 0.24 | -0.69 | -8.04 | -1.61 | 49.82 | - | - | - | - |
|
Non-Controlling Interest
|
- | - | - | - | - | - | - | - | - | - | - |
|
Net Income
|
-45.54 | -38.53 | -24.56 | -32.90 | -17.41 | -11.22 | 668.63 | -21.14 | -33.15 | 52.76 | -37.48 |
Supplemental
Per share data, derived & other items — not part of the income statement
in millions USD unless noted
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY | Dec 31, 2019 2019 FY | Dec 31, 2018 2018 FY | Dec 31, 2017 2017 FY | Dec 31, 2016 2016 FY | Dec 31, 2015 2015 FY |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Depreciation & Amortization
|
- | - | - | - | - | - | - | - | - | - | - |
|
EBITDA
|
-55.69 | -42.47 | -37.51 | -34.49 | -25.08 | -18.28 | -31.23 | -20.99 | -34.06 | -52.76 | -37.51 |
|
Earnings Per Share (Basic)
|
-1.49 | -1.26 | -0.81 | -1.08 | -0.58 | -0.36 | 17.17 | - | - | - | - |
|
Diluted EPS
|
-1.49 | -1.26 | -0.81 | -1.08 | -0.58 | -0.36 | 14.44 | - | - | - | - |
|
Weighted Average Shares
|
30.49 | 30.46 | 30.44 | 30.44 | 30.04 | 30.82 | 38.95 | - | - | - | - |
|
Diluted Weighted Avg Shares
|
30.49 | 30.46 | 30.44 | 30.44 | 30.04 | 30.82 | 46.32 | - | - | - | - |
|
Comprehensive Income
|
- | -38.53 | -25.38 | -34.05 | -16.71 | -9.85 | 668.78 | -20.63 | -33.98 | -52.50 | -37.53 |